The economic cost of thyroid cancer in France and the corresponding share associated with treatment of overdiagnosed cases
Thyroid cancer incidence in France has increased rapidly in recent decades. Most of this increase has been attributed to overdiagnosis, the major consequence of which is overtreatment. We aimed to estimate the cost of thyroid cancer management in France and the corresponding cost proportion attributable to the treatment of overdiagnosed cases. (Source: Value in Health)
Source: Value in Health - March 13, 2023 Category: International Medicine & Public Health Authors: Mengmeng Li, Filip Meheus, Stephanie Polazzi, Patricia Delafosse, Fran çoise Borson-Chazot, Arnaud Seigneurin, Raphael Simon, Jean-Damien Combes, Luigino Dal Maso, Marc Colonna, Antoine Duclos, Salvatore Vaccarella, Thyroid Cancer Group FRANCIM Source Type: research

Use of Big Data and Ethical Issues for Populations with Substance Use Disorder
We describe a state-level effort to address aspects of the opioid epidemic through public health research, which has resulted in an expansive data resource combining dozens of administrative data sources in Massachusetts. The Massachusetts Public Health Data Warehouse is a public health innovation that serves as an example of how to address the complexities of balancing data privacy and access to data for public health and health services research. (Source: Value in Health)
Source: Value in Health - March 13, 2023 Category: International Medicine & Public Health Authors: Elizabeth Evans, Kimberley H. Geissler Source Type: research

Using time trade-off values to estimate EQ-5D-Y value sets: an exploratory study
This study aimed to explore the feasibility of using cTTO values alone to estimate EQ-5D-Y-3L value sets. (Source: Value in Health)
Source: Value in Health - March 13, 2023 Category: International Medicine & Public Health Authors: Zhihao Yang, Jie Jiang, Pei Wang, Jing Wu, Yu Fang, Da Feng, Xiaoyu Xi, Nan Luo Tags: Brief Report Source Type: research

A Rapid Review on the Value of Biobanks Containing Genetic Information
Increasing access to health data through biobanks containing genetic information has the potential to expand the knowledge base and thereby improve screening, diagnosis, and treatment options for many diseases. However, while privacy concerns and risks surrounding genetic data sharing are well documented, direct evidence in favour of the hypothesized benefits of data integration is scarce, which complicates decision-making in this area. Therefore, the objective of this study is to summarize the available evidence on the research and clinical impacts of biobanks containing genetic information, so as to better understand how...
Source: Value in Health - March 12, 2023 Category: International Medicine & Public Health Authors: Elisabet Rodriguez Llorian, Nicola Kopac, Louloua Ashikhusein Waliji, Kennedy Borle, Nick Dragojlovic, Alison M. Elliott, Larry D. Lynd Tags: Systematic Literature Review Source Type: research

The HTA-informed Decision-Making by GBA/IQWiG in Germany and NICE in England: The Role of Budget Impact
The aim of our study was to test (official) evaluation criteria including the potential role of budget impact (BI) on health technology assessment (HTA) outcomes published by the Federal Joint Committee (GBA) and the Institute for Quality and Efficiency in Health Care (IQWiG) in Germany as well as the National Institute for Health and Care Excellence (NICE) in England. (Source: Value in Health)
Source: Value in Health - March 12, 2023 Category: International Medicine & Public Health Authors: Ramon Schaefer, Diego Hern ández, Till Baernighausen, Peter Kolominsky-Rabas, Michael Schlander Source Type: research

25 Years of Health Economics and Outcomes Research: An Exploration of Value in Health
(Source: Value in Health)
Source: Value in Health - March 10, 2023 Category: International Medicine & Public Health Authors: Michael F. Drummond, C. Daniel Mullins Tags: Editorial Source Type: research

Do reimbursement recommendations by the Canadian Agency for Drugs and Technology in Health translate into coverage decisions for orphan drugs in the Canadian province of Ontario?
This study is the first to look at this question for orphan drugs which are at the centre of policy attention. (Source: Value in Health)
Source: Value in Health - March 6, 2023 Category: International Medicine & Public Health Authors: Anna-Maria Fontrier, Panos Kanavos Source Type: research

The impact of subclinical hypothyroidism on the quality of life during pregnancy: Mapping EQ5D 5L and ThypPRO-39
It is unknown how subclinical hypothyroidism (SubHypo) influences the quality of life (QoL) during pregnancy. (Source: Value in Health)
Source: Value in Health - March 4, 2023 Category: International Medicine & Public Health Authors: Tuzil Jan, Pilnackova Filkova Barbora, Watt Torquil, Jiskra Jan, Koudelkova Marcela, Novotna Eva, Tuzilova Klara, Dolezal Tomas, Bartakova Jana Source Type: research

Measuring PROMs with Computer Adaptive Testing after an operative intervention of an extremity fracture
Patient-Reported Outcomes Measurement Information System (PROMIS) enables the use of computer adaptive testing (CAT). The aim of the present prospective cohort study was to compare the most commonly used disease-specific instruments with PROMIS CAT questionnaires in trauma patients. (Source: Value in Health)
Source: Value in Health - March 3, 2023 Category: International Medicine & Public Health Authors: Roos J.M. Havermans, Koen W.W. Lansink, Taco Gosens, Mariska A.C. de Jongh Source Type: research

Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making
Real-world data (RWD) and real-world evidence (RWE) can provide extensive information on healthcare for use in health technology assessment (HTA) and decision making. However, there is a lack of consensus surrounding the appropriate data governance (DG) practices for RWD/E. Data sharing is also a large concern, especially considering evolving data protection regulations. Our objective is to propose recommendations for international standards of evaluating the acceptability of RWD governance practices. (Source: Value in Health)
Source: Value in Health - March 1, 2023 Category: International Medicine & Public Health Authors: Oriol Sol à-Morales, Katla Sigurðardóttir, Ron Akehurst, Linda A. Murphy, Jorge Mestre-Ferrandiz, David Cunningham, Gérard de Pouvourville Tags: Policy Perspectives Source Type: research

Table of Contents
(Source: Value in Health)
Source: Value in Health - March 1, 2023 Category: International Medicine & Public Health Source Type: research

Copyright/Subscription
(Source: Value in Health)
Source: Value in Health - March 1, 2023 Category: International Medicine & Public Health Source Type: research

Editorial Board
(Source: Value in Health)
Source: Value in Health - March 1, 2023 Category: International Medicine & Public Health Source Type: research

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
Value Health. 2017;20(8):1009-1022. (Source: Value in Health)
Source: Value in Health - February 25, 2023 Category: International Medicine & Public Health Tags: Correction Source Type: research

Best Practice Recommendations for Electronic Patient-Reported Outcome (ePRO) Dataset Structure and Standardization to Support Drug Development
The ePRO Dataset Structure and Standardization Project is a multi-stakeholder initiative formed by Critical Path Institute ’s Patient-Reported Outcome (PRO) Consortium and Electronic Clinical Outcome Assessment (eCOA) Consortium to address issues related to electronic patient-reported outcome (ePRO) dataset structure and standardization and to provide best practice recommendations for clinical trial sponsors and elect ronic clinical outcome assessment (eCOA) providers. Given the many benefits of utilizing electronic modes to capture PRO data, clinical trials are increasingly using these methods, yet there are challenges ...
Source: Value in Health - February 25, 2023 Category: International Medicine & Public Health Authors: Stacie Hudgens, Scottie Kern, Alexandra I. Barsdorf, Sally Cassells, Alison Rowe, Bellinda L. King-Kallimanis, Cheryl Coon, Geoff Low, Sonya Eremenco Tags: Policy Perspectives Source Type: research